|
|
Volumn 2, Issue 6, 1999, Pages 361-374
|
|
Advances in the pharmacotherapy of migraine. How knowledge of pathophysiology is guiding drug development.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PLASMA PROTEIN;
SEROTONIN;
DRUG DESIGN;
HUMAN;
MIGRAINE;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
REVIEW;
SECRETION;
TRIGEMINUS GANGLION;
VASOCONSTRICTION;
VASODILATATION;
BLOOD PROTEINS;
DRUG DESIGN;
HUMANS;
MIGRAINE DISORDERS;
SEROTONIN;
TRIGEMINAL GANGLION;
VASOCONSTRICTION;
VASODILATION;
|
|
EID: 0033288087
PISSN: 11745886
EISSN: None
Source Type: Journal
DOI: 10.2165/00126839-199902060-00001 Document Type: Review |
|
Times cited : (20)
|
|
References (176)
|
